Skip to main content
Caplight Logo









NeoGenix Biosciences

NeoGenix Biosciences

Private
SydneyHealthcare & Life Scienceshttps://www.neogenixbiosciences.com/

Last Round

Pre Seed

Mar 11, 2024

Total Funding Raised

$145,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

NeoGenix Biosciences is a biotechnology company that develops AI-powered and microfluidic platforms to enhance sperm identification and selection for IVF procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

IVF technologymicrofluidicssperm selectionfertility techmedical AIassisted reproductive technologyARTmale infertilityembryology toolsAI image analysisbiomimetic devicesnon-obstructive azoospermiaNOAfertility clinic softwaremedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeoGenix Biosciences Comparables

Compare NeoGenix Biosciences with similar companies based on industry and business-model similarity.

NeoGenix Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iPreg Inc.
86%
Koek Biotechnology Ltd.
77%
Memphasys Ltd
75%

NeoGenix Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedMar 11, 2024
AcceleratorOct 26, 2023

Key People

Founding team and executive leadership

Steven Vasilescu

Co-Founder and CEO

Founding Team

Saeed Fathi

Technical Advisor & Fractional CTO

Executive Team

NeoGenix Biosciences Investors

Notable investors and investment history

NeoGenix Biosciences investors
InvestorRounds
Australian Medical AngelsAccelerator
The George Institute for Global HealthAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 39% MoM, reaching 798.

  • Mar 11, 2024

    $65K round led by Virtus Health

NeoGenix Biosciences Filings

Explore SEC and related filing metadata, where available.

NeoGenix Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NeoGenix Biosciences's valuation, stock price, and market status.

Is NeoGenix Biosciences a public or private company?

NeoGenix Biosciences is a private company.

What is the current stock price of NeoGenix Biosciences?

NeoGenix Biosciences is a private company with no public stock price. Caplight tracks NeoGenix Biosciences's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is NeoGenix Biosciences worth (valuation)?

Valuation information for NeoGenix Biosciences is not publicly available.

Can I buy NeoGenix Biosciences stock?

NeoGenix Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NeoGenix Biosciences's last funding round?

NeoGenix Biosciences's most recent funding round was Pre Seed on March 11, 2024.

Who are the main investors in NeoGenix Biosciences?

Key investors in NeoGenix Biosciences include Australian Medical Angels, The George Institute for Global Health.

Will NeoGenix Biosciences IPO soon?

No public IPO plans have been announced for NeoGenix Biosciences.

How can I track NeoGenix Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeoGenix Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range6
Year Founded2022
Last FundingMar 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?